[{"Assets_0_Q3_USD":56483000.0,"CommonStockSharesOutstanding_0_Q3_shares":104707116.0,"EarningsPerShareBasic_1_Q3_USD":-0.31,"EarningsPerShareBasic_3_Q3_USD":-0.84,"EarningsPerShareDiluted_1_Q3_USD":-0.31,"EarningsPerShareDiluted_3_Q3_USD":-0.84,"NetIncomeLoss_1_Q3_USD":-32886000.0,"NetIncomeLoss_3_Q3_USD":-84549000.0,"StockholdersEquity_0_Q3_USD":-251015000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":104703000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":100136000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":104703000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":100136000.0,"Ticker":"MNKD","CIK":"899460","name":"MANNKIND CORP","OfficialName":"MannKind Corporation Common Stock","form":"10-Q","period":"20170930","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"898029416.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20171107"}]